EGFR and neoplasm: The analysis of single nucleotide variants in KRAS, NRAS, PIK3CA, BRAF, and EGFR using cfDNA has been shown to have >80% concordance when compared to tumor tissue of colorectal [60,61], lung [34,62], and breast [59,61] cancer patients.